Bismuth-Based quintuple therapy: a step beyond quadruple regimens in H. Pylori treatment and the impact of patient compliance. [PDF]
BMC GastroenterolDertli R +6 more
europepmc +1 more source
Potassium-competitive acid blockers and advances in the management of patients with acid-related diseases: a narrative review. [PDF]
Front PhysiolQiao X, Li P.
europepmc +1 more source
Response to Tutorial Drug-Drug Interactions by EM Sellers. [PDF]
Clin Transl SciDas JL, Ajavon-Hartmann AT, Schmith VGD.
europepmc +1 more source
Impact of Acid Suppressants on the Development of <i>Clostridioides difficile</i> Infection and Possible Preventive Effects of Probiotic Formulations. [PDF]
Infect Drug ResistShiraishi C, Kato H, Iwamoto T.
europepmc +1 more source
Esomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells. [PDF]
J Biochem Mol ToxicolJoha Z +4 more
europepmc +1 more source
<i>In vitro</i> anti-<i>Helicobacter pylori</i> activity of ilaprazole used alone and in combination with other components of quadruple therapy. [PDF]
Microbiol SpectrZhang Z +10 more
europepmc +1 more source
Endoscopic Examination and Long-Term Use of Proton Pump Inhibitors for Gastroesophageal Reflux Disease Treatment in Japan. [PDF]
Drug Healthc Patient SafTakami A +4 more
europepmc +1 more source
Precision therapy guided by genotypic antibiotic resistance for <i>Helicobacter pylori</i> eradication: A prospective, randomized controlled trial. [PDF]
World J GastroenterolXu Y +9 more
europepmc +1 more source
Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-line <i>Helicobacter pylori</i> eradication: a randomized controlled trial. [PDF]
Ther Adv GastroenterolTai WC +9 more
europepmc +1 more source